CAS: 1076-74-0; 5-Methoxy-2-Methyl-1H-Indole

该化合物是替代的单极衍生物,其特征是五方的甲氧基组和双方的甲氧基组,该化合物是有机合成的多用途中间体,特别是在制药,农用化学品和实用材料的制作方面;其结构特征提高了电益替代和交叉反应的回动性,使其对建设复杂的七环系统很有价值;甲氧基组提高了有机溶剂的溶性,促进了下游加工;在标准条件下,它具有很高的纯度和稳定性,是需要精确分子修改的研究和工业应用的可靠建筑块.

结构式图片

相似化合物

1968-13-4 21778-81-4 13314-85-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

5-甲氧基吲哚 5-Methoxylindole 1006-94-6
2-Bromo-5-Methoxy-1H-Indole 169383-96-4
2-Methyl-3-Methylthio-5-Methoxy-1H-Indole 50461-37-5
5-Methoxy-2-Methyl-3-(Phenylthio)-1H-Indole 98055-12-0
5-甲氧基-2-甲基-1H-吲哚-3-羧酸 5-Methoxy-2Methyl-1H-Indole-3-Carboxylic Acid 32387-22-7

合成工艺路线路线简述

  • 合成目标产物 5-Methoxy-2-Methylindole 主要起始原料 P-Anisidine And Hydroxyacetone
  • (文献来源)合成步骤主要原料 P-Anisidine 和 Hydroxyacetone
1-(苯磺酰基)-5-甲氧基吲哚置于正丁基锂,Sodium Hydroxide体系中,用 四氢呋喃,乙醇,水 用作溶剂,化学反应生成5-甲氧基-2-甲基吲哚
参考文献:Discovery Of A First-In-Class,Potent,Selective,And Orally Bioavailable Inhibitor Of The P97 Aaa Atpase (Cb-5083)
标题:Discovery Of A First-In-Class,Potent,Selective,And Orally Bioavailable Inhibitor Of The P97 Aaa Atpase (Cb-5083)
摘要:The Aaa-Atpase P97 Plays Vital Roles In Mechanisms Of Protein Homeostasis,Including Ubiquitin Proteasome System (Ups) Mediated Protein Degradation,Endoplasmic Reticulum-Associated Degradation (Brad),And Autophagy. Herein We Describe Our Lead Optimization Efforts Focused On In Vitro Potency,Adme,And Pharmaceutical Properties That Led To The Discovery Of A Potent,Atp-Competitive,D2-Selective,And Orally Bioavailable P97 Inhibitor 71,Cb-6083. Treatment Of Tumor Cells With 71 Leads To Significant Accumulation Of Markers Associated With Inhibition Of Ups And Erad Functions,Which Induces Irresolvable Proteotoxic Stress And Cell,Death. In Tumor Bearing Mice,Oral Administration Of 71 Causes Rapid Accumulation Of Markers Of The Unfolded Protein Response (Upr) And Subsequently Induces Apoptosis Leading To Sustained Antitumor Activity In In Vivo,Xenograft Models Of Both Solid And Hematological Tumors. 71 Has Been Taken Into Phase I Clinical Trials In Patients With Multiple Myeloma And Solid Tumors.
Doi:10.1021/acs.Jmedchem.5B01346

专利信息


专利号:US-6531477-B1
优先权日:1998-10-13
标 题:6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
发明人:MARKWALDER JAY A; SEITZ STEVEN P; SHERK SUSAN R
权利人:DU PONT PHARM CO
摘要:The present invention relates to the synthesis of a novel class of pyrazolo[3,4-d]pyrimidin-4-ones of formula (I), alternatively represented by the tautomer (II):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cyclin dependent kinase 1-8 and their regulatory subunits know as cyclins A-H, K, N, and T.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:US-6559152-B2
优先权日:1998-10-13
标 题 :6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
发明人:MARKWALDER JAY A; SEITZ STEVEN P; SHERK SUSAN R
权利人:DU PONT PHARM CO
摘要:The present invention relates to the synthesis of a novel class of pyrazolo[3,4-d]pyrimidin-4-ones of formula (I), alternatively represented by the tautomer (II):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cyclin dependent kinase 1-8 and their regulatory subunits know as cyclins A-H, K, N, and T.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:US-9334275-B2
优先权日:2011-12-19
标题:Processes for preparing indoles
发明人:YOSHIKAI NAOHIKO; WEI YE
权利人:UNIV NANYANG TECH
摘要:Methods for the synthesis of an indole in provided. Methods comprise oxidizing a N-aryl imine in the presence of a palladium-based catalyst, an oxidant, and a solvent.

专利号:US-2021198197-A1
优先权日:2019-12-03
标题:Method for synthesizing indomethacin and analogue thereof
发明人:CHEN ZHILONG; LU HELIN
权利人:UNIV HUAZHONG SCIENCE TECH
摘要:The present disclosure belongs to the technical field of indomethacin synthesis, and discloses a method for synthesizing an indomethacin and an analogue thereof. The method for synthesizing an indomethacin and an analogue thereof includes steps of: introducing an alkyl group, an aromatic ring or a heteroaromatic ring directly at the C2 position of indole, a carboxylic acid fragment at the C3 position of the indole, and an aroyl group at the N1 position of the indole through palladium-catalyzed reactions. The present disclosure solves a problem: most of the existing indomethacin synthesis methods are achieved by construction of an indole ring and modification; simple structural changes of an indomethacin molecule based on this synthetic strategy often require de novo synthesis; the late modification and structure-activity relationship study of the indomethacin molecule have lengthy synthetic steps.

专利号:US-4160862-A
优先权日:1972-06-12
标 题 :1-Acyl-3-(amino-lower-alkyl)indoles
发明人:ZENITZ BERNARD L
权利人:STERLING DRUG INC
摘要:1-Acyl-3-(amino-lower-alkyl)indoles, useful as anti-inflammatory agents, are prepared either by acylation of a 3-(amino-lower-alkyl)indole; by Fisher indole synthesis from an N'-acylphenylhydrazine and an amino-lower-alkanone; by alkylation of an amine with a 1-acyl-3-(halo-lower-alkyl)indole; or by reductive alkylation of a 1-acyl-3-indole-lower-alkylcarboxaldehyde.

专利号:RU-2151148-C1
优先权日:1994-04-22
标 题:3-indolylpiperidines, method of their synthesis, pharmaceutical composition and method of its preparing
上海威远精细氟科技发展有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.shwychem.com
企业联系电话:021-64251386 64253204👤
📞上海威远精细氟科技发展有限公司 ⚠️参考联系方式

电话:021-64251386 64253204

传真:021-64253354
邮箱:wdchen@shwychem.com
通信地址: 上海梅陇路130号华东理工科技大楼
邮编: 200237
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海梅陇路130号华东理工科技大楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
常州长锦医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.cjpharmtech.com
电话: 0519-83818068 18951215668👤
📞常州长锦医药科技有限公司 ⚠️参考联系方式

销售电话:0519-83818068 18951215668
邮箱:sales@cjpharmtech.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题:Copper-Catalyzed Synthesis And Anticancer Activity Evaluation Of Indolo[1,2-A]Quinoline Derivatives
作者:Adisak Thanetchaiyakup,Suparerk Borwornpinyo,Hassayaporn Rattanarat,Phongthon Kanjanasirirat,Kedchin Jearawuttanakul,Sawinee Seemakhan,Nutthawat Chuanopparat,Paiboon Ngernmeesri |发布日期:2021.10
摘要:A Simple And Effective One-Pot Synthesis Of Substituted Indolo[1,2-A]Quinolines Has Been Developed. The Desired Products Were Obtained In Up To 98% Yield When Substituted 2-Methyindoles Were Treated With 2-Iodobenzaldehyde In The Presence Of Cs2Co3, Cui And L-Proline. Our Mechanistic Study Confirmed That The Reaction Sequence Involved An Intermolecular Knoevenagel Reaction Followed By An Intramolecular

合成参考文献


摘要:Uemura, M., Science of Synthesis Knowledge Updates, (2010) 4, 1.
摘要:Aguilar, E.; López, L. A., Science of Synthesis Knowledge Updates, (2014) 2, 93.
摘要:Joule, J. A., Science of Synthesis Knowledge Updates, (2010) 2, 270.
摘要:Witt, D., Science of Synthesis Knowledge Updates, (2019) 2, 287.
摘要:Franciò, G.; Leitner, W.; Alsters, P. L., Science of Synthesis: Stereoselective Synthesis, (2011) 1, 507.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知